Targeting TGF-beta overexpression: maximizing the antifibrotic actions of angiotensin II blockade in anti-Thy1 glomerulonephritis.
Peters
H
H
Division of Nephrology, University of Utah, Salt Lake City, USA.
Border
W A
WA
Noble
N A
NA
D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D000818:Animals; D004656:Enalapril / Q000627:therapeutic use; D005921:Glomerulonephritis / Q000188:drug therapy*; D019808:Losartan / Q000627:therapeutic use; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D018800:Thy-1 Antigens / Q000276:immunology*; D016212:Transforming Growth Factor beta / Q000096:biosynthesis*
D018800:Thy-1 Antigens; D016212:Transforming Growth Factor beta; D000804:Angiotensin II; D004656:Enalapril; D019808:Losartan